whether abruptly stopping clopidogrel (Plavix) can worsen cardiovascular outcomes

March 2008

A recent JAMA study has people asking whether abruptly stopping clopidogrel (Plavix) can worsen cardiovascular outcomes.

Acute coronary syndrome patients seem to have a higher risk of death or heart attack within 90 days of stopping clopidogrel.

Researchers speculate it's a possible "rebound effect."

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

more attention to following treatment guidelines
Diabetes whether aggressive blood-glucose lowering is HARMFUL in some type 2 diabetes patients
Diabetes cinnamon DOESN'T lower blood glucose in diabetes patients
Hypertension Blood pressure is often measured wrong
Cardiology whether abruptly stopping clopidogrel (Plavix) can worsen cardiovascular outcomes
Cardiology calcium MIGHT increase heart attack risk
Respiratory & Allergy neti pots or "nose bidets" for sinus problems, etc
Respiratory & Allergy Is Advair better than Spiriva for COPD
Women's Health whether caffeine increases the risk of miscarriage
Practice confusion on what changes a pharmacist can make to a C-II Rx
Supplements new focus on vitamin D deficiency
Neurology & Pain give long-acting opioids more frequently than the preferred dosing schedule recommended by the product manufacturer
Psychiatry FDA is warning about a possible increased risk of suicidal thoughts with antiepileptic drugs or Chantix (varenicline)
Dermatology how to relieve dry skin